BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15659971)

  • 1. Fever without apparent source on clinical examination.
    McCarthy P
    Curr Opin Pediatr; 2005 Feb; 17(1):93-110. PubMed ID: 15659971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fever without source in children 0 to 36 months of age.
    Ishimine P
    Pediatr Clin North Am; 2006 Apr; 53(2):167-94. PubMed ID: 16574521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.
    Benito-Fernández J; Raso SM; Pocheville-Gurutzeta I; SánchezEtxaniz J; Azcunaga-Santibañez B; Capapé-Zache S
    Pediatr Infect Dis J; 2007 Aug; 26(8):667-71. PubMed ID: 17848875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of febrile children without localising signs after pneumococcal conjugate vaccine.
    Waddle E; Jhaveri R
    Arch Dis Child; 2009 Feb; 94(2):144-7. PubMed ID: 18539684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of fever without source in infants and children.
    Baraff LJ
    Ann Emerg Med; 2000 Dec; 36(6):602-14. PubMed ID: 11097701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of serious bacterial infections in febrile infants with respiratory syncytial virus infection.
    Titus MO; Wright SW
    Pediatrics; 2003 Aug; 112(2):282-4. PubMed ID: 12897274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumococcal conjugate vaccine for young children.
    Selman S; Hayes D; Perin LA; Hayes WS
    Manag Care; 2000 Sep; 9(9):49-52, 54, 56-7 passim. PubMed ID: 11116663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotype prevalence of occult pneumococcal bacteremia.
    Alpern ER; Alessandrini EA; McGowan KL; Bell LM; Shaw KN
    Pediatrics; 2001 Aug; 108(2):E23. PubMed ID: 11483833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infant immunisation with a pneumococcal conjugate vaccine: from the age of two months, for all infants.
    Prescrire Int; 2006 Dec; 15(86):227-33. PubMed ID: 17167934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7-valent pneumococcal conjugate vaccine: new preparation. Prevents rare invasive infections in infants.
    Prescrire Int; 2002 Feb; 11(57):7-10. PubMed ID: 11985376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergency department epidemiology of pneumococcal bacteremia in children since the institution of widespread PCV7 vaccination.
    Mistry RD; Wedin T; Balamuth F; McGowan KL; Ellison AM; Nelson KA; McLoughlin RJ; Alpern ER
    J Emerg Med; 2013 Dec; 45(6):813-20. PubMed ID: 23992851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive pneumococcal infections in children with asplenia.
    Schutze GE; Mason EO; Barson WJ; Kim KS; Wald ER; Givner LB; Tan TQ; Bradley JS; Yogev R; Kaplan SL
    Pediatr Infect Dis J; 2002 Apr; 21(4):278-82. PubMed ID: 12075756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Occult bacteremia in Sótero del Río Hospital: Experience after pneumococcal conjugated vaccine].
    Budnik I; Sandoval A; Prado A; Labbé M; Peña A; Viviani T
    Rev Chilena Infectol; 2017 Apr; 34(2):133-140. PubMed ID: 28632827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serious and invasive pediatric pneumococcal disease: epidemiology and vaccine impact in the USA.
    Tan TQ
    Expert Rev Anti Infect Ther; 2010 Feb; 8(2):117-25. PubMed ID: 20109042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine.
    Haddy RI; Perry K; Chacko CE; Helton WB; Bowling MG; Looney SW; Buck GE
    Pediatr Infect Dis J; 2005 Apr; 24(4):320-3. PubMed ID: 15818291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumococcal bacteremia in febrile infants presenting to the emergency department before and after the introduction of the heptavalent pneumococcal vaccine.
    Carstairs KL; Tanen DA; Johnson AS; Kailes SB; Riffenburgh RH
    Ann Emerg Med; 2007 Jun; 49(6):772-7. PubMed ID: 17337092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections.
    Levine DA; Platt SL; Dayan PS; Macias CG; Zorc JJ; Krief W; Schor J; Bank D; Fefferman N; Shaw KN; Kuppermann N;
    Pediatrics; 2004 Jun; 113(6):1728-34. PubMed ID: 15173498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.
    Kaplan SL; Barson WJ; Lin PL; Romero JR; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Mason EO
    Pediatr Infect Dis J; 2013 Mar; 32(3):203-7. PubMed ID: 23558320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection.
    Ampofo K; Bender J; Sheng X; Korgenski K; Daly J; Pavia AT; Byington CL
    Pediatrics; 2008 Aug; 122(2):229-37. PubMed ID: 18676537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bacteremic pneumococcal pneumonia].
    Pineda Solas V; Pérez Benito A; Domingo Puiggros M; Larramona Carrera H; Segura Porta F; Fontanals Aymerich D
    An Esp Pediatr; 2002 Nov; 57(5):408-13. PubMed ID: 12467543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.